4//SEC Filing
Xencor Inc 4
Accession 0001209191-13-055658
$XNCRCIK 0001326732operating
Filed
Dec 5, 7:00 PM ET
Accepted
Dec 6, 2:07 PM ET
Size
12.1 KB
Accession
0001209191-13-055658
Insider Transaction Report
Form 4
Xencor IncXNCR
FLEMING JONATHAN
Director
Transactions
- Conversion
Common Stock
2013-12-06+17,429→ 790,881 total(indirect: By Partnership) - Conversion
Series A-1 Preferred Stock
2013-12-06−2,397,704→ 0 total(indirect: By Partnership)→ Common Stock (773,452 underlying) - Conversion
Common Stock
2013-12-06+773,452→ 773,452 total(indirect: By Partnership) - Conversion
Series A-1 Preferred Stock
2013-12-06−54,031→ 0 total(indirect: By Partnership)→ Common Stock (17,429 underlying)
Footnotes (3)
- [F1]Every 3.1 shares of the Series A-1 Preferred Stock is convertible into 1 share of the Issuer's Common Stock at any time, at the holder's election, and has no expiration date.
- [F2]These securities are owned by Oxford Bioscience Partners V, L.P. ("Oxford"). The Reporting Person is a general partner of OBP Management V L.P., which is the sole general partner of Oxford. The Reporting Person disclaims beneficial ownership in those securities in which he does not have a pecuniary interest, and this report shall not be deemed an admission that he is the beneficial owner of these securities for purposes of Section 16.
- [F3]These securities are owned by mRNA Fund V, L.P. ("mRNA"). The Reporting Person is a general partner of OBP Management V L.P., which is the sole general partner of mRNA. The Reporting Person disclaims beneficial ownership in those securities in which he does not have a pecuniary interest, and this report shall not be deemed an admission that he is the beneficial owner of these securities for purposes of Section 16.
Documents
Issuer
Xencor Inc
CIK 0001326732
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001326732
Filing Metadata
- Form type
- 4
- Filed
- Dec 5, 7:00 PM ET
- Accepted
- Dec 6, 2:07 PM ET
- Size
- 12.1 KB